Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Cipla EU to invest an additional EUR 3 million in Ethris

Posted On: 2024-06-18 17:12:32 (Time Zone: IST)


Cipla Limited today announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited (hereinafter together referred as "Cipla") will invest an additional EUR 3 million in Ethris GmbH ("Ethris"), a global leader in delivering mRNAs directly to the respiratory system. This additional investment through a convertible loan will accelerate Cipla's participation in the mRNA space.

Cipla had earlier invested EUR 15 million in Ethris in 2022. This additional investment reaffirms Cipla's confidence in Ethris's proprietary mRNA platform and its potential for patients in emerging markets. Together, Cipla and Ethris are working towards a long-term strategic partnership to fast-track innovative mRNA-based treatments. During the COVID19 pandemic, mRNA vaccines gained importance due to the first regulatory approvals for SARS-CoV-2. mRNA-based medicines have a huge potential in several indications as infectious disease vaccines, therapeutic cancer vaccines, and protein replacement therapies.

Umang Vohra, Managing Director & Global Chief Executive Officer of Cipla, said, "At Cipla, we strive to dial-up our focus and investment towards innovative modalities and bring new age therapies to emerging countries, including India. The follow-on investment in Ethris will help get cutting-edge healthcare solutions like mRNA-based therapies to the Global South. As we lead Cipla ahead, we will continue to work towards building an innovative future and build brands that re-enforce our ethos of 'caring for life'."

Dr. Carsten Rudolph, CEO of Ethris, added, "The additional investment by Cipla further validates the broad potential of our platform and Ethris' innovative approaches to developing respiratory RNA-based medicines. We deeply value this ongoing relationship to bring effective solutions to developing countries. The capital will enable us to continue advancing our pipeline and we look forward to providing an update on our lead program in the near term."

Shares of Cipla Limited was last trading in BSE at Rs. 1565.30 as compared to the previous close of Rs. 1543.45. The total number of shares traded during the day was 36181 in over 2912 trades.

The stock hit an intraday high of Rs. 1571.15 and intraday low of 1537.20. The net turnover during the day was Rs. 56364890.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Meson Valves India Ltd acquires Milindpra Castings Pvt Ltd

ideaForge Technology Ltd invests in GalaxEye Space Solutions Pvt Ltd

Suryoday Small Finance Bank Ltd sanctions term loan facility of Rs. 10 crore to Star Housing Finance Ltd

Tata Elxsi Ltd reports lower Q1 FY2024-25 net profit of Rs. 184.07 crores

JTL Industries Ltd Q1FY25 consolidated PAT at Rs. 30.70 crores

Vashu Bhagnani Industries Ltd Q1 FY2024-25 consolidated profit at Rs. 5.68 crores

KCP Sugar and Industries Corporation Ltd reports Rs. 54.11 crores consolidated PAT in Q1FY25

Kesoram Industries Ltd Q1FY25 consolidated loss at Rs. 62.02 crores

SG Finserve Ltd Q1 FY2025 net profit slips QoQ to Rs. 19.38 crores

Storage Technologies and Automation Ltd to open new sales branch office at Thane West

UGRO Capital Opens a New Branch Office in Indore to Empower MSMEs

Angel One Reaffirms Robust Data Security and Compliance

Zydus receives tentative approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg

Juniper Green Energy Secures 480 MW in Hybrid PPAs with GUVNL and NTPC

JLR India announced a strong start to FY25

IRCTC & DMRC QR Code Ticketing under 'One India - One Ticket' Initiative

State Bank of India's Senior Unsecured Long Term Bond Issuance

Oriental Rail Infrastructure Ltd secures orders worth Rs. 19.33 crore

Sula Vineyards Limited - Sales Update - Q1 FY25

Ahasolar Technologies Ltd receives order worth Rs. 45 lacs

Westside launches its 229th store in Faridabad

Satin Creditcare Secures 15 Million Euros Debt Funding from OeEB

Pecos Hotels and Pubs Limited recommends final dividend of Rs. 3

TVS Motor Company Launches 2024 TVS Apache RTR 160 - Racing Edition

Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets

Revolt Motors Launches - Industry-First Finance Scheme: '4 Chauke Offer'

OK Play India Limited approves IPO of OK Play Auto Pvt Ltd

Rail Vikas Nigam Limited signs MoU with IMS Consultancy Pvt Ltd

Sky Industries Ltd to participate in Textile Fairs-India 2024

Greaves Finance Ltd partners with ACKO to facilitate seamless EV ownership across India

ITCONS E-Solutions Limited receives contract worth Rs. 41.15 lakhs

GE Power India Ltd receives order from MRPL

Mahan Energen Ltd ceases to be wholly owned subsidiary of Adani Power Ltd

Rail Vikas Nigam Ltd receives LOA from Nagpur Metro

Adani Ports and Special Economic Zone Ltd receives LOI for Berth No.13 at Deendayal Port

Mehai Technology Limited receives order from Sungevity Enterprises Pvt Ltd

Eraaya Lifespaces Ltd Q1FY2025 PAT up at Rs. 95.49 lakhs

Rajnish Wellness Ltd Q1FY25 profit at Rs. 16.70 lakhs

Delta Corp Ltd posts consolidated PAT of Rs. 21.68 crores in Q1 FY2024-25

R S Software India Ltd consolidated Q1 FY25 net profit drops QoQ to Rs. 4.58 crore

Tanishq Opens Expansive Showroom at Omaxe Chowk

Zaggle receives prestigious awards for superior brand and product innovation

Rail Vikas Nigam Limited signs MoU with TATWEER Middle East and Africa LLC

Fusion Micro Finance Ltd is now Fusion Finance Ltd

BLS International Holding Anonim ┼×irketi, Turkey successfully completes acquisition of 100% stake in iDATA

Abans Holdings Limited gets registration of IFSC branch

Advait Infractech Ltd receive LOI from KPI Green Energy Ltd for orders

KIMS HOSPITALS announces acquisition of 200-bed multi-specialty hospital in Vizag

Spectrum Foods Limited converts 1,82,21,671 shares into fully-paid up on receipt of call money

Shilpa Pharma Lifesciences Ltd, Unit 2, Raichur, Karnataka has cleared the ANVISA-Brazil GMP inspection


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020